Latest Ambalal Sarabhai Enterprises stock price
Ambalal Sarabhai Enterprises P/E Ratio
AMBALALSA • P/E ratio not applicable due to negative earnings
P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable
Company has reported losses in the last 2 quarters. P/E ratio is not applicable during loss periods.
Consecutive Loss Quarters: 2
Current EPS: ₹0.64
Recent Quarterly Performance
| Quarter | EPS (₹) | Net Profit (₹ Cr) | Status |
|---|---|---|---|
| Sept 2025 | -0.07 | -1 | Loss |
| Mar 2025 | -0.04 | 0 | Loss |
| Jun 2025 | 1.07 | 8 | Profit |
| Sept 2024 | 0.34 | 3 | Profit |
| Mar 2024 | 1.18 | 9 | Profit |
| Jun 2024 | 0.05 | 0 | Profit |
| Dec 2024 | 0.29 | 2 | Profit |
| Sept 2023 | 0.14 | 1 | Profit |
Profitable Companies in Healthcare Sector
Other profitable companies in Healthcare sector with valid P/E ratios
Sector Average PE
53.4
Sector Median PE
31.12
Lowest PE
1.5
Profitable Companies
132
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |